Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
gptkb:Phase_I
|
| gptkbp:developer |
Metabasis Therapeutics
|
| gptkbp:hasDevelopmentCode |
MTX-512
|
| gptkbp:hasTherapeuticUse |
treatment of obesity
treatment of type 2 diabetes |
| https://www.w3.org/2000/01/rdf-schema#label |
MTX512
|
| gptkbp:mechanismOfAction |
glucagon receptor antagonist
|
| gptkbp:status |
discontinued
|
| gptkbp:synonym |
gptkb:MTX512
MTX 512 MTX-512 |
| gptkbp:bfsParent |
gptkb:Z88DK
gptkb:Memotech_MTX |
| gptkbp:bfsLayer |
7
|